Physician profile
Judson Dale Davies
NPI 1972776888
$67,479.26
in general payments reported to CMS, 2019-2025
46 companies · $47K in 2025
The $47K reported for 2025 was more than what 98% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,071 · 2020: $754 · 2021: $2,489 · 2022: $2,136 · 2023: $11K · 2024: $3,233 · 2025: $47K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $35K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $16K · Travel and Lodging: $5,411 · Food and Beverage: $4,183 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $35,230.75 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $16,170.00 |
| Travel and Lodging | $5,410.53 |
| Food and Beverage | $4,183.43 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $33,844.05 | 2020-2025 | Rybrevant, Carvykti, Erleada |
| Janssen Scientific Affairs, LLC | $13,115.04 | 2019-2025 | Erleada, Akeega, Pipeline |
| Bayer Healthcare Pharmaceuticals INC. | $12,183.46 | 2022-2025 | |
| Ferring Pharmaceuticals INC. | $1,439.78 | 2019-2025 | Adstiladrin, Menopur |
| Boston Scientific Corporation | $1,118.59 | 2019-2025 | Ams 700, Lithovue, Rezum Generator |
| Dendreon Pharmaceuticals LLC | $920.57 | 2019-2023 | Provenge |
| Procept Biorobotics Corporation | $630.05 | 2022-2025 | Aquabeam Robotic System, Aquabeam System |
| Janssen Global Services, LLC | $500.00 | 2025 | |
| Intuitive Surgical, INC. | $286.59 | 2019-2022 | |
| Baxter Healthcare | $282.62 | 2023-2024 | Tisseel |
| Axonics, INC. | $271.51 | 2021-2023 | Axonics |
| Astellas Pharma US INC | $229.79 | 2019-2022 | |
| Pfizer INC. | $197.56 | 2019-2020 | |
| Immunitybio, INC. | $184.58 | 2025 | |
| Palette Life Sciences, INC. | $178.31 | 2022 |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $174.15 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $167.62 | 2019-2021 | |
| Karl Storz Endoscopy-America | $165.67 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $160.05 | 2020-2025 | Imfinzi |
| Sumitomo Pharma America, INC. | $147.43 | 2023-2025 | Orgovyx |
| Agiliti Surgical, INC. | $137.91 | 2019-2025 | Sonablate Hifu, Koelis Trinity Mri/US Fusion |
| Teleflex LLC | $130.68 | 2021 | |
| Novartis Pharmaceuticals Corporation | $125.38 | 2025 | |
| Merck Sharp & Dohme LLC | $102.29 | 2022-2023 | Keytruda, Lynparza |
| Myovant Sciences INC. | $98.94 | 2021-2022 | |
| Antares Pharma, INC. | $88.51 | 2019-2024 | Xyosted |
| Abbvie INC. | $85.47 | 2019-2025 | |
| Srs Medical Systems, INC. | $84.14 | 2021 | |
| Sun Pharmaceutical Industries INC. | $49.62 | 2024-2025 | |
| Verity Pharmaceuticals INC. | $48.95 | 2022-2023 | Trelstar |
| Endo USA, INC. | $39.02 | 2024-2025 | Xiaflex |
| Amgen INC. | $33.49 | 2020-2022 | |
| Coloplast Corp | $32.21 | 2020-2022 | |
| 180 Medical, INC. | $31.36 | 2019-2021 | |
| Myriad Genetic Laboratories, INC. | $29.40 | 2020 | |
| Calyxo, INC. | $25.33 | 2025 | Cvac Aspiration System |
| Urogen Pharma, INC. | $21.95 | 2025 | |
| Ge Healthcare | $21.75 | 2024 | |
| Telix Pharmaceuticals | $20.82 | 2025 | Illuccix |
| Progenics Pharmaceuticals, INC. | $18.81 | 2023 | Pylarify |
| Valencia Technologies Corporation | $17.09 | 2025 | Ecoin Device Kit |
| Cook Medical LLC | $14.47 | 2025 | Resonance |
| Allergan, INC. | $12.14 | 2020 | |
| Blue Earth Diagnostics | $12.11 | 2020 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judson Davies listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.